Skip to main content

Table 12 The cost-effectiveness analysis in the 12-month intervention period (reversion rate)

From: The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design

Group C (yuan) E (%) C/E ΔC/ΔE
The treatment group 21156020.3 41.8 506124.9  
The control group 18815209.0 27.8 676806.1 167213.7